Limb Revascularization in Patients with Diabetes Mellitus

Cover Page

Cite item

Full Text

Abstract

The review describes morbidity, mortality and possible complication rates for diabetic patients with peripheral arteries disease. The article demonstrates the modern tendency in the surgical treatment of peripheral arteries atherosclerosis, shows and compares worldwide results of endovascular and open revascularization. The authors have assessed the risk of amputation for patients with diffuse peripheral arteries disease and described basic treatment principals for better chronic ischemic ulcer healing.

About the authors

L. A. Bokeria

Sechenov University

Author for correspondence.
Email: ashihara@mail.ru
Moscow, Russian Federation

V. S. Arakelyan

Sechenov University

Email: ashihara@mail.ru
Moscow, Russian Federation

V. G. Papitashvili

Sechenov University

Email: ashihara@mail.ru
Moscow, Russian Federation

Sh. Sh. Tsurtsumiya

Bakulev Scientific Center of Cardiovascular Surgery

Email: ashihara@mail.ru
Moscow, Russian Federation

References

  1. Armstrong EJ, Waltenberger J, Rogers JH. Percutaneous coronary intervention in patients with diabetes: current concepts and futuredirections. J Diabetes Sci Technol. 2014;8: 581—589. doi: 10.1177/1932296813517058
  2. Armstrong EJ, Rutledge JC, Rogers JH. Coronary artery revascularizationin patients with diabetes mellitus. Cir­culation. 2013;128: 1675—85.
  3. Hirsch AT, Hartman L, Town RJ et al. National health care costs of peripheral arterial disease in the Medi­care population. Vasc Med. 2008;13: 209—15. doi: 10.1177/1358863X08089277
  4. Marso SP, Hiatt WR. Peripheral arterial disease in pa­tients with diabetes. J Am Coll Cardiol. 2006;47: 921—9. doi: 10.1016/j.jacc.2005.09.065
  5. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-ana­lysis: glycosylated hemoglobinand cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141: 421—31. doi: 10.7326/0003-4819-141-6-200409210-00007
  6. American Diabetes Association. Economic cost of diabetes in the US in 2007. Diabetes Care. 2008;31: 596—615.
  7. Lateel H, Stevens MJ, Varni J. All transretinoic acid sup­presses matrix metalloproteinase activity and increases collagen synthesis in diabetic human skin in organ culture. Am J Pathol. 2004;165: 167—74.
  8. Varani J, Warner RL, Gharaee-kermani M, et al. Vita­min A antagonizes decreased cell growthand elevated collagen-degrading matrix metalloproteinases and stimu­lates collagen accumulation in naturally aged human skin. J Invest Dermatol. 2000;114: 480—6.
  9. Wear-Magi Hik, lee J, Conejero A, et al. Use of topical RAGE in diabetic wounds increase end neovasculari­zation and granular tissue formation. Ann Plast Surg. 2004;52: 12—22.
  10. Marston WA, Davies SW, Armstrong B, et al. Natural history of limbs with arterialinsufficiency and chronic ulceration treated with revascularization. J. Vasc Surg. 2006;44: 108—14.
  11. Schaper NC, Nabuurs-Franssen MH, Huijberts MS. Peri­pheral vascular disease and type 2 diabetes mellitus. Dia­betes Metab Res Rev. 2000;16 Suppl 1: S11—S15.
  12. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc. 1985;33: 13—8.
  13. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26: 3333—41. doi: 10.2337/diacare.26.12.3333
  14. Haltmayer M, Mueller T, Horvath W, et al. Impact of athe­rosclerotic risk factors on the anatomical distribution of peripheral arterial disease. Int Angiol. 2001;20: 200—7.
  15. Ridker PM, Cushman M, Stampfer MJ, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97: 425—8.
  16. Сermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993;82: 513—20.
  17. Vinik AI, Erbas T, Park TS, et al. Platelet dysfunction in type 2 diabetes. Diabetes Care. 2001;24: 1476—85.
  18. Williams SB, Cusco JA, Roddy MA, et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996; 27: 567—74.
  19. De Vriese AS, Verbeuren TJ, Van de Voorde J, et al. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000;130: 963—74.
  20. Inoguchi T, Li P, Umeda F, et al. High glucose level and free fatty acid stimulate reactive oxygen species produc­tion through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000;49: 1939—45.
  21. Geng YJ, Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol. 2002;22: 1370—80.
  22. Forsythe RO, Jones KG, Hinchliffe RJ. Distal bypasses in patients with diabetes and infrapopliteal disease: tech­nical considerations to achieve success. Int J Low Extrem Wounds. 2014;13: 347—362.
  23. Singh S, Armstrong EJ, Sherif W, et al. Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty. Vasc Med. 2014;19: 307—14. doi: 10.1177/1358863X14538330]
  24. Reynolds K, He J. Epidemiology of the metabolic syndrome. Am J Med Sci. 2005;330: 273—9. doi: 10.1097/000 00441-200512000-00004
  25. BeckmKullo IJ, Bailey KR, Kardia SL, et al. Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study. Vasc Med. 2003;8: 237—42.
  26. Dick F, Diehm N, Galimanis A, et al. Surgical or endo­vascular revascularization in atients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg. 2007;45: 751—61. doi: 10.1016/j.jvs.2006.12.022]
  27. Awad S, Karkos CD, Serrachino-Inglott F, et al. The impact of diabetes on current revascularisation practice and clinical outcome in patients with critical lower limb ischaemia. Eur J Vasc Endovasc Surg. 2006;32: 51—9. doi: 10.1016/j.ejvs.2005.12.019
  28. Hinchliffe RJ, Andros G, Apelqvist J, et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes Metab Res Rev. 2012;28 Suppl 1: 179—217. doi: 10.1002/dmrr.2249
  29. Katelnitsky II, Muradov AM. Possibilities of reconstruc­tion and restoration of lower leg arteries during critical ischemia in patients with atherosclerotic lesions of the lower extremities. Modern problems of science and edu­cation. 2015; 2—1. URL: http://www.science-education.ru/ ru/article/view?id=18533
  30. Aslanov AD, Logvina OE, Kugotov AG. Experience in the treatment of critical lower limb ischemia on the background of diffuse damage to arteries. Angiology and Vascular Surgery. 2012;18(4): 125—7.
  31. Gavrilenko AV, Voronov DA, Kotov AE. Comprehensive treatment of patients with critical lower limb ischemia in combination with diabetes. Annals of surgery. 2014;3: 41—6.
  32. Kolobova OI, Subbotin YuG, Kozlov AV. In-situ autoge­nous shunting in patients with distal arterial occlusions of the lower extremities in case of diabetes mellitus. Sur­gery. Magazine them. N.I. Pirogov. 2011;7: 18—23.
  33. Kim CY, Naidu S, Kim YH. Supermicrosurgery in pari­neal and soleus perforation-based free flap coverage of food defects caused by occlusive vascular disease. Plast. Reconst. Surg. 2010;126(2): 499—507.
  34. Kanyushin NV, Tuvanova EP, Deryagin EV. Surgical treatment of critical lower limb ischemia in the general surgical department. Bulletin of the East Siberian Scien­tific Center of the Siberian Branch of the Russian Academy of Medical Sciences. 2012;4(86): 60—1.
  35. Pomposelli FM. A decade of experience with dorsal pedis artery: analysis of outcome in more than 1000 case. J. Vase. Surg. 2003;37(2): 307—15.
  36. Frankini AD, Pezella MV. Foot revascularization in pa­tients with critical limb ischemia. Rev Port Cir Cardio­torac Vasc. 2003 Apr-Jun; 10 (2): 75—81.
  37. Biancari F, Juvonen T. Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis. European journal of vascular and endovascular surgery: the official journal of the Euro­pean Society for Vascular Surgery. 2014;47: 517—2.
  38. Eroshkin IA. X-ray diagnostic correction of lesions of lower limb arteries in patients with diabetes mellitus and its role in the complex treatment of diabetic foot syn­drome. PhD thesis of Doctor of Med. Sciences. Moscow. 2010. p.58.
  39. Kawarada O, Yasuda S, Nishimura K, et al. Effect of single tibial artery revascularization on microcirculation in the setting of critical limb ischemia. Circulation Car­diovascular interventions. 2014;7: 684—91.
  40. Bosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. Journal of vascular surgery. 2012;55: 390—8.
  41. Rastan A, Brechtel K, Krankenberg H, et al. Sirolimus-eluting stents for treatment of infrapopliteal arteries re­duce clinical event rate compared to bare-metal stents: long-term results from a randomized trial. J Am Coll Cardiol. 2012;60: 587—91.
  42. Ambler GK, Radwan R, Hayes PD, et al. Atherectomy for peripheral arterial disease. The Cochrane database of systematic reviews. 2014;3: CD006680.
  43. Piyaskulkaew C, Parvataneni K, Ballout H, et al. Laser in infrapopliteal and popliteal stenosis 2 study (LIPS2): Long-term outcomes of laser-assisted ball angioplasty versus ball angioplasty for below knee peripheral arterial disease. Catheter Cardiovasc Interv. 2015;86: 1211—8.
  44. Mehaffey JH, Hawkins RB, Fashandi A. Lower extremity bypass for critical limb ischemia decreases major adverse limb events with equivalent cardiac risk compared with endovascular intervention. J Vasc Surg. 2017 Jun 24. pii: S0741—5214 (17) 31143—6.
  45. Slovut DP, Lipsitz EC. Surgical technique and peripheral artery disease. Circulation. 2012;126: 1127—38.
  46. Conte MS. Critical appraisal of surgical revascularization for critical limb ischemia. Journal of vascular surgery. 2013;57: 8S—13S.
  47. Tanaka Y, Uemura T, Ayabe S, et al. Revisiting Micro­surgical Distal Bypass for Critical Limb Ischemia J. Re­constr Microsurg. 2016;32(8): 608—14.
  48. Watanabe Y, Onozuka A, Obitsu Y, et al. Skin perfusion pressure measurement to assess improvement in peripheral circulation after arterial reconstruction for critical limb ischemia. Ann Vasc Dis. 2011;4: 235—40.
  49. Yamada T, Ohta T, Ishibashi H, et al. Clinical reliability and utility of skin perfusion pressure measurement in ischemic limbs — comparison with other noninvasive diagnostic methods. J Vasc Surg. 2008;47: 318—23.
  50. Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischaemia of Leg (BASIL) trial: analysis of amputation free and overall survival by treat­ment received. J Vasc Surg. 2010;51: 18S—31S.
  51. Mochizuki Y, Hoshina K, Shigematsu K et al. Distal by­pass to a critically ischemic foot increases the skin per­fusion pressure at the opposite site of the distal anasto­mosis. Vascular. 2016;24(4): 361—7.
  52. Guo X, Shi Y, Huang X, Et al. Features analysis of lower extremity arterial lesions in 162 diabetes patients. J Dia­betes Res. 2013;78(1): 360—9.
  53. Shinozaki N. The effectiveness of skin perfusion pressure measurements during endovascular therapy in determining the endpoint in critical limb ischemia. Intern Med. 2012; 51(12): 1527—30.
  54. Leeds FH, Gilfillan RS. Importance of profunda femoris artery in the revascularization of the ischemic limb. Arch Surg. 1961;82: 25—31.
  55. Malgor RD, Ricotta JJ, Bower TC, et al. Common femo­ral artery endarterectomy for lower-extremity ischemia: evaluating the need for additional distal limb revasculari­zation. Ann Vasc Surg. 2012;26: 946—56.
  56. Taurino M, Persiani F, Ficarelli R Et al. The Role of the Profundoplasty in the Modern Management of Patient with Peripheral Vascular Disease. Ann Vasc Surg. 2017 May 24. pii: S0890—5096 (17) 30694—5.
  57. Akhmetov AV. Reconstruction of the deep femoral artery in the complex treatment of patients with chronic critical lower limb ischemia. PhD thesis. Nalchik. 2006. p.58.
  58. Derksen WJ, Gisbertz SS, Hellings WE, et al. Predictive risk factors for restenosis after remote superficial femoral artery endarterectomy. Eur J Vasc Endovasc Surg. 2010;39: 597—603.
  59. Kang JL, Patel VI, Conrad MF, et al. Common femoral artery occlusive disease: contemporary results follow­ing surgical endarterectomy. J Vasc Surg. 2008;48: 872—7.

Copyright (c) 2019 Bokeria L.A., Arakelyan V.S., Papitashvili V.G., Tsurtsumiya S.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies